Monograph Title Sort ascending | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION | Assay | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Constitute Erythromycin Ethylsuccinate for Oral Suspension as directed in the labeling, and proceed as directed in the Assay under Erythromycin Ethylsuccinate Oral Suspension. to: Constitute Erythromycin Ethylsuccinate for Oral… Read More |
ERYTHROMYCIN DELAYED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Test 1: Change Buffer stage Medium: 0.05 M pH 6.8 phosphate buffer (see Reagents, Indicators, and Solutions—Buffer Solutions) to: Buffer stage Medium: 0.05 M pH 6.8 phosphate buffer (see Reagents,… Read More |
ENZACAMENE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Analysis: Change CU = concentration of enzacamene in the Sample solution (mg/mL) to: CU = concentration of Enzacamene in the Sample solution (mg/mL) |
ENSULIZOLE | IDENTIFICATION | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In B.: Change The retention time of the major peak of the Sample solution exhibits maxima and minima at the same wavelengths as those of the Standard solution, as obtained in the Assay. to: The retention time of the major… Read More |
ECONAZOLE NITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Econazole Related Compound C RS: Change 1-(4-Chlorobenzyl)-3-{2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazol-3-ium nitrate (salt). C25H21Cl14N3O4 569.… Read More |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test for dutasteride/Tier 2/Medium: Change 10 g/L of cetyltrimethylammonium bromide and 750,000 USP units of activity/mg of pepsin, purified in 0.1 N hydrochloric acid; 900 mL to: Dissolve 10 g of… Read More |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Dihydrodutasteride RS: Change N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide. to: N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5α-androstane-17β-carboxamide. |
DOXYCYCLINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
DOXYCYCLINE HYCLATE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
DOXYCYCLINE HYCLATE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
DOXYCYCLINE HYCLATE | CHEMICAL INFORMATION | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change 1025.87 to: 1025.88 |
DOXYCYCLINE HYCLATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Table 2, footnote b: Change (4S,4aR,5S,5aR,6R,12aS)-2-Acetyl-4-(dimethylamino)-4a,5a,6,12a-tetrahydro-3,5,10,12,12a-pentahydroxy-6-methyl-tetracene-1,11-dioxo-2-naphthacenecarboxamide. to: (4S,4aR,5S,5a… Read More |
DOXYCYCLINE HYCLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change 480.13 to: 480.90 |
DOXYCYCLINE FOR INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
DOXYCYCLINE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
DOXORUBICIN HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DOXORUBICIN HYDROCHLORIDE INJECTION | IMPURITIES/Organic Impurities | USPNF 2022 Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DOXORUBICIN HYDROCHLORIDE | ASSAY | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Procedure/System suitability solution: Add link to USP Store for USP Epirubicin Hydrochloride RS |
DOXAZOSIN MESYLATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change CS = concentration of the corresponding USP Doxazosin Related Compound RS or USP Doxazosin Mesylate RS (for calculating unspecified impurities) in the Standard solution (mg/mL) to: CS… Read More |
DOFETILIDE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change β-[(p-Methanesulfonamidophenethyl)methylamino]methane sulfono-p-phenetidide to: N-{4-[2-(Methyl{2-[4-(methylsulfonamido)phenoxy]ethyl}amino)ethyl]phenyl}methanesulfonamide |
DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 29-Sep-2023 | 1-Oct-2023 | NA | NA | In Dissolution 〈711〉/Test 8/Tolerances: Change The percentage of the labeled amount of valproic acid (C8H16O2) dissolved at the times specified conform to Dissolution <711>, Acceptance… Read More |
DIMENHYDRINATE TABLETS | OTHER COMPONENTS/8-Chlorotheophylline | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change CU = nominal concentration of dimenhydrinate in the Sample solution (mg/mL) to: CU = determined concentration of dimenhydrinate in the Sample solution, as obtained in the Assay… Read More |
DILUTED ISOSORBIDE MONONITRATE | IMPURITIES | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Organic Impurities/Standard solution: Change isosorbide related compound A to: isosorbide mononitrate related compound A AND In System suitability/Suitability requirements/Relative standard… Read More |
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES | IDENTIFICATION | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change A. The UV-Vis spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. to: A. The UV spectrum of the major peak of the Sample solution… Read More |
DIGOXIN TABLETS | ASSAY/Procedure | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In Chromatographic system: Change Column: 4.2-mm × 25-cm; 5-μm packing L1 to: Column: 4.6-mm × 25-cm; 5-µm packing L1 |
DIGOXIN TABLETS | ASSAY | USPNF Online | Online | 29-Sep-2023 | 1-Oct-2023 | NA | NA | In Procedure/Analysis: Change CU = nominal concentration of in the Sample solution (µg/mL) to: CU = nominal concentration of digoxin in the Sample solution (µg/mL) |
DICYCLOMINE HYDROCHLORIDE | IDENTIFICATION | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | In B. Identification Tests—General 〈191〉, Chemical Identification Tests, Chloride: Change Meets the requirements when tested as specified in test B. to: Meets the requirements of the test for amine… Read More |
DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉: Move Test 2 after Test 1 |
DIAZOXIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In footnote a in Table 2: Change 7-Chloro-2H-benzothiadiazin-3(4H)-one 1,1-dioxide. to: 7-Chloro-2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxide. |
DEXTROMETHORPHAN HYDROBROMIDE ORAL SOLUTION | Assay | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Chromatographic system and Procedure: Change C is the concentration, in mg per mL, of USP Dextromethorphan Hydrobromide RS, on the anhydrous basis, in the Standard preparation; to: C is the concentration, in mg per mL… Read More |
DEXTRATES | ASSAY/Dextrose Equivalent | USPNF Online | Online | 31-Mar-2023 | 1-May-2023 | NA | NA | In Analysis: Change rA = peak response of each saccharide degree of polymerization (DP1–DP3) in the Sample solution (If any peaks of DP4 and above are observed in the sample, take the summation… Read More |
DEXAMETHASONE SODIUM PHOSPHATE INJECTION | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change Result = (rU/rS) × (CS/CU) × (Mr1/Mr22) × 100 to: Result = (rU/r… Read More |
DAPSONE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Dissolution 〈711〉/Standard solution: Change USP Dapsone RS of a known concentration in Medium to: (L/1000) mg/mL of USP Dapsone RS in Medium, where L is the label claim in mg/Tablet. Transfer a portion of this… Read More |
DACARBAZINE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In System suitability/Suitability requirements/Signal-to-noise ratio: Change NTL 10, to: NLT 10, |
CRANBERRY FRUIT DRY JUICE | DEFINITION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | Change procyanidin A2 to: procyanidin A2 |
CRANBERRY FRUIT DRY JUICE | IDENTIFICATION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In A./Standard solution B: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS AND In A./System suitability/Suitability requirements/Derivatization reagent B/White light… Read More |
CRANBERRY FRUIT DRY JUICE | COMPOSITION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Content of Proanthocyanidins/Standard stock solution: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS AND In Content of Proanthocyanidins/Analysis: Change Use the absorbance recorded for Standard… Read More |
CRANBERRY FRUIT DRY JUICE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In USP Reference Standards 〈11〉: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS |
COCOYL CAPRYLOCAPRATE | SPECIFIC TESTS | USPNF Online | Online | 23-Feb-2024 | 1-May-2024 | NA | NA | In Fats and Fixed Oils 〈401〉, Procedures, Hydroxyl Value/Analysis: Change Calculate the acid value as directed in the chapter. to: Calculate the hydroxyl value as directed in the chapter. |
CLOMIPHENE CITRATE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | In Table 2: Change Clomiphene related compound A 0.87 – 2.0 to: Clomiphene related compound A 0.87 1.0 2.0 |
CHLORTETRACYCLINE HYDROCHLORIDE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | Change 7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride to: (4S,4aS,5aS,6S,12aS)-7-Chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-… Read More |
CHLOROPROCAINE HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Sample solution: Change Transfer about 100 mg of chloroprocaine hydrochloride to a 100-mL volumetric flask, dissolve in 40 mL of methanol, and dilute with water to volume. to: Transfer a volume of Injection, equivalent to about 100 mg of… Read More |
CHLORHEXIDINE GLUCONATE ORAL RINSE | IMPURITIES/Limit of p-Chloroaniline | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change Standard solution: 1.0 µg/mL of USP p-Chloroaniline RS in Diluent to: Standard solution: 0.001 mg/mL of USP p-Chloroaniline RS in Diluent AND In Analysis: Change Result = (rU… Read More |
CEFTIOFUR HYDROCHLORIDE | ASSAY/Procedure | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Analysis: Change Calculate the percentage of ceftiofur (C19H17N5O7S3) in the portion of Ceftiofur Hydrochloride taken: Result = (rU/rS… Read More |
CEFDINIR FOR ORAL SUSPENSION | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 AND In USP Reference Standards 〈11〉/USP Cefdinir Related Compound B RS: Change C14H13N4O4S… Read More |
CEFDINIR CAPSULES | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 AND In USP Reference Standards 〈11〉/USP Cefdinir Related Compound B RS: Change C14H13N4O4S… Read More |
CEFDINIR | IMPURITIES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Organic Impurities/Table 2/footnote a: Change 1N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine. to: N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine. |